SenoRx Board Appoints John T. Buhler as Chief Executive Officer and Member of Board of Directors
March 16 2010 - 1:50PM
SenoRx, Inc. (Nasdaq:SENO) announced today that its Board of
Directors appointed acting Chief Executive Officer John T. Buhler
as the company's new Chief Executive Officer and a member of the
Board of Directors. The appointment is effective immediately. As
previously announced, SenoRx Chairman and Chief Executive Officer
Lloyd H. Malchow passed away on March 14, 2010, while on a medical
leave of absence. Mr. Buhler will now serve as SenoRx's
President and Chief Executive Officer.
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally
invasive medical devices used by breast care specialists for the
diagnosis and treatment of breast cancer, including its EnCor®
vacuum-assisted breast biopsy system and Contura™ MLB catheter for
delivering radiation to the tissue surrounding the lumpectomy
cavity following surgery for breast cancer. SenoRx's field
sales organization serves over 2,000 breast diagnostic and
treatment centers in the United States. In addition, SenoRx sells
several of its products through distribution partners in more than
30 countries outside the U.S. The company's line of breast care
products includes biopsy disposables, biopsy capital equipment,
diagnostic adjunct products and therapeutic disposables. SenoRx is
developing additional minimally invasive products for the diagnosis
and treatment of breast cancer. For more information, visit the
company's website at
www.senorx.com.
The SenoRx, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3605
CONTACT: SenoRx, Inc.
Lila Churney, Director of Investor Relations
949.362.4800 ext.132
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jul 2023 to Jul 2024